N/A
Manufactured by Amneal Pharmaceuticals LLC
20,768 FDA adverse event reports analyzed
Last updated: 2026-04-14
OXYMORPHONE HYDROCHLORIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Amneal Pharmaceuticals LLC. The most commonly reported adverse reactions for OXYMORPHONE HYDROCHLORIDE include DEPENDENCE, DEATH, TOXICITY TO VARIOUS AGENTS, OVERDOSE, DRUG DEPENDENCE. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for OXYMORPHONE HYDROCHLORIDE.
Out of 11,590 classified reports for OXYMORPHONE HYDROCHLORIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 20,768 FDA FAERS reports that mention OXYMORPHONE HYDROCHLORIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include DEPENDENCE, DEATH, TOXICITY TO VARIOUS AGENTS, OVERDOSE, DRUG DEPENDENCE, DRUG ABUSE. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Amneal Pharmaceuticals LLC in connection with OXYMORPHONE HYDROCHLORIDE. Always verify the specific product and NDC with your pharmacist.